Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

被引:158
作者
Jernström, H
Lerman, C
Ghadirian, P
Lynch, HT
Weber, B
Garber, J
Daly, M
Olopade, OI
Foulkes, WD
Warner, E
Brunet, JS
Narod, SA
机构
[1] Univ Toronto, Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
[3] Ctr Hosp Univ Montreal, Epidemiol Res Unit, Res Ctr, Montreal, PQ, Canada
[4] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA
[5] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[7] Dana Farber Canc Inst, Div Canc Epidemiol & Control, Boston, MA 02115 USA
[8] Fox Chase Canc Ctr, Div Basic Sci & Populat Sci, Philadelphia, PA 19111 USA
[9] Univ Chicago, Med Ctr, Canc Risk Clin, Sect Hematol & Oncol, Chicago, IL 60637 USA
[10] McGill Univ, Dept Med, Montreal, PQ, Canada
[11] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[12] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[13] Toronto Sunnybrook Reg Canc Ctr, Div Med Oncol, Toronto, ON, Canada
[14] Univ Lund Hosp, Dept Oncol, Jubileum Inst, S-22185 Lund, Sweden
关键词
D O I
10.1016/S0140-6736(99)04336-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Early age at first full-term pregnancy and increasing parity are associated with a reduced risk of breast cancer. However, whether pregnancy decreases the risk of early-onset hereditary breast cancer is unknown. There is concern that pregnancy may increase breast-cancer risk in carriers of BRCA1 and BRCA2 germline mutations. We aimed to establish whether pregnancy is a risk factor for hereditary breast cancer. Methods We did a matched case-control study of breast cancer in women who carry deleterious BRCA1 or BRCA2 mutations. Cases were carriers who developed breast cancer by age 40 years, and controls were carriers of the same age without breast cancer, or who were diagnosed with breast cancer after age 40 years. Women who had undergone preventive mastectomy, hysterectomy, or oophorectomy, or who were diagnosed with ovarian cancer before the age at which breast cancer was diagnosed in the matched case were excluded. Information about pregnancies and pregnancy outcome was derived from a questionnaire completed by women in the course of genetic counselling. Findings A higher proportion of cases than controls had had a full term pregnancy (173/236 vs 146/236; odds ratio 1.71 [95% CI 1.13-2.62], p=0.01). The mean number of births was also greater for cases than for controls (1.62 vs 1.38, p=0.04). The risk increased with the number of births and did not diminish with time since last pregnancy. There were no significant differences in age at first birth or age at last birth between cases and controls. Interpretation Carriers of the BRCA1 and BRCA2 mutations who have children are significantly more likely to develop breast cancer by age 40 than carriers who are nulliparous. Each pregnancy is associated with an increased cancer risk. An early first pregnancy does not confer protection for carriers of BRCA1 or BRCA2 mutations.
引用
收藏
页码:1846 / 1850
页数:5
相关论文
共 31 条
[1]  
Bassler R, 1970, Curr Top Pathol, V53, P1
[2]   CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER [J].
BERAL, V ;
REEVES, G .
LANCET, 1993, 341 (8852) :1102-1102
[3]   Risk factors for breast cancer according to family history of breast cancer [J].
Colditz, GA ;
Rosner, BA ;
Speizer, FE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (06) :365-371
[4]  
DICKSON R, 1996, DIS BREAST, P15
[5]   GROWTH-FACTORS IN BREAST-CANCER [J].
DICKSON, RB ;
LIPPMAN, ME .
ENDOCRINE REVIEWS, 1995, 16 (05) :559-589
[6]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[7]  
Egan KM, 1998, CANCER EPIDEM BIOMAR, V7, P359
[8]   BRCA1 inhibition of estrogen receptor signaling in transfected cells [J].
Fan, S ;
Wang, JA ;
Yuan, R ;
Ma, Y ;
Meng, Q ;
Erdos, MR ;
Pestell, RG ;
Yuan, F ;
Auborn, KJ ;
Goldberg, ID ;
Rosen, EM .
SCIENCE, 1999, 284 (5418) :1354-1356
[9]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[10]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886